Drug
Cep 701
Cep 701: highest development phase Phase 2, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| CEP-701 60mg NCT00030186 | Phase 2 | Leukemia, Myeloid |
Latest
No recent events.
Follow Cep 701 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.